ClinicalTrials.Veeva

Menu

the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome

S

Sohag University

Status

Unknown

Conditions

Irritable Bowel Syndrome

Treatments

Diagnostic Test: H. pylori stool antigen

Study type

Observational

Funder types

Other

Identifiers

NCT04847401
Soh-Med-21-04-03

Details and patient eligibility

About

Evaluating any possible relationship between irritable bowel syndrome occurrence and Helicobacter pylori infection

Enrollment

80 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients will be selected according to Rome IV criteria for the diagnosis of IBS, which include:

Recurrent abdominal pain at least 1 day/week in the last 3 months, with two or more of the following criteria:

  • Related to defecation
  • Associated with a change in frequency of stool
  • Associated with a change in form of stool. Criteria achieved for the last 3 months with symptom onset at least 6 months before diagnosis

Exclusion criteria

  • • Rectal bleeding

    • Anemia
    • Weight loss
    • Onset after 50 years of age
    • Recent antibiotic use
    • Abnormal abdominal examination (organomegaly, lump)
    • Family history of colorectal cancer.
    • Family history of inflammatory bowel disease, or celiac disease.

Trial design

80 participants in 2 patient groups

Group 1
Description:
patients with Irritable Bowel Syndrome
Treatment:
Diagnostic Test: H. pylori stool antigen
Group 2
Description:
normal
Treatment:
Diagnostic Test: H. pylori stool antigen

Trial contacts and locations

0

Loading...

Central trial contact

Reham Mohy Kamel, MBBCh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems